Here is more information about the NIH trials and what Dr. Diemert and other infectious disease experts have to say about the progress in the monkeypox vaccine.
NIH trials seek answers on monkeypox vaccine delivery
Latest News
The GW VRU Director, Dr. David Diemert, co-authored an article assessing the value of public health, economic, and societal value of developing a vaccine to prevent and reduce the transmission of Schistosomiasis. Endemic in 78 countries, it is estimated that approximately 236 million people were…
VRU Director, Dr. David Diemert, attends the annual Joint Coordinating Board meeting of TDR (Special Programme for Research and Training in Tropical Diseases) of the WHO in Geneva, Switzerland